Related Experiment Video
Updated: Sep 4, 2025

08:20
Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
13.2K
Animal Models and Pathogenesis of Ulcerative Colitis
Xin Gao1, Jia Li1, Xueping Pang1
1Shandong University of Traditional Chinese Medicine, Shandong, China.
Computational and Mathematical Methods in Medicine
|July 21, 2022
Summary
Rats are the optimal animal models for ulcerative colitis (UC) research. Compound methods are most effective for modeling UC, involving factors like nitric oxide and intestinal flora.
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- Ulcerative colitis (UC) is a significant inflammatory bowel disease requiring effective prediction models.
- Understanding UC pathogenesis is crucial for developing targeted therapies.
Purpose of the Study:
- To review and analyze diverse animal models for ulcerative colitis (UC).
- To summarize animal selection criteria, model development, and pathogenic mechanisms in UC models.
Main Methods:
- A comprehensive literature review of research papers published in major scientific databases over the last five years.
- Analysis focused on experimental animals, modeling techniques, and underlying UC pathogenesis.
Main Results:
- Rats are identified as the preferred experimental animals for UC modeling.
- The compound method is the most successful modeling technique, surpassing chemical and immune stimulation methods.
- Key pathogenic factors in UC include nitric oxide (NO), prostaglandins (PG), proinflammatory cytokines (IL, TNF-α), and alterations in intestinal flora.
Conclusions:
- Established methods for creating UC animal models facilitate targeted selection for future research.
- This review provides a foundation for selecting appropriate animal models to study UC pathogenesis and test interventions.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
304
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
304
Drugs for Treatment of Ulcerative Colitis in IBD
230
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
230

